Table 2.
Age (years) | Median | |
Range | (35–86) | |
Sex | Female | 67 (%) |
Male | 64 (%) | |
Histology | Non-small cell | 101 (%) |
Small cell | 30 (%) | |
Node status | Positive | 73 (%) |
Negative | 58 (%) | |
Chemotherapy | Concurrent | 89 (%) |
Sequential | 32 (%) | |
None | 8 (%) | |
Unspecified | 2 (%) | |
Prescribed dose | 60–66 Gy | 101 (%) |
45 vGy | 7 (%) | |
45 Gy (b.i.d.) | 23 (%) |